Rare diseases
Investigational molecules
Locations
Back to Germany739 clinical trials in Heidelberg, Germany across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
GermanyStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
GermanyPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
GermanyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
GermanyFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
GermanyA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
GermanyPhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
GermanyPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
GermanyA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
GermanySafety Study of CD19.CAR T Cells in Patients with Autoimmune‑Associated Severe Interstitial Lung Fibrosis
GermanyEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
GermanyStudy of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of TTR amyloidosis cardiovascular complications. Studies evaluating new therapeutic approaches for pulmonary hypertension.
Research includes evaluation of novel compounds for heart conditions and preventive therapies.
Comprehensive research in lung cancer, bladder cancer, and melanoma treatments. Advanced trials for various lymphomas and leukemias using innovative therapeutic approaches.
Focus on targeted therapies and immunological approaches in cancer treatment.
Groundbreaking research in kidney transplantation with innovative immune system modification approaches. Studies exploring new methods to improve transplant outcomes.
Emphasis on developing personalized immunosuppression strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
